These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12648061)

  • 1. Transient leukaemia--a benign form of leukaemia in newborn infants with trisomy 21.
    Zipursky A
    Br J Haematol; 2003 Mar; 120(6):930-8. PubMed ID: 12648061
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydrops fetalis and neonatal leukemia in Down syndrome.
    Zipursky A; Rose T; Skidmore M; Thorner P; Doyle J
    Pediatr Hematol Oncol; 1996; 13(1):81-7. PubMed ID: 8718505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A newborn with Down syndrome-transient myeloproliferative disorder.
    Akdag A; Tunç B; Oğuz S; Dilli D; Dilmen U
    J Perinat Med; 2010 Jul; 38(4):445-7. PubMed ID: 20443668
    [No Abstract]   [Full Text] [Related]  

  • 4. Prenatally diagnosed non-immune hydrops caused by congenital transient leukaemia.
    Donnenfeld AE; Scott SC; Henselder-Kimmel M; Dampier CD
    Prenat Diagn; 1994 Aug; 14(8):721-4. PubMed ID: 7991512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Congenital transient leukemia: a case report].
    Li-Thiao-Te V; Bourges-Petit E; Capiod JC; Horle B; Micheli J; Morin G; Maingourd Y; Pautard B
    Arch Pediatr; 2008 Jan; 15(1):33-6. PubMed ID: 18162385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481.
    Massey GV; Zipursky A; Chang MN; Doyle JJ; Nasim S; Taub JW; Ravindranath Y; Dahl G; Weinstein HJ;
    Blood; 2006 Jun; 107(12):4606-13. PubMed ID: 16469874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.
    Brink DS
    Adv Anat Pathol; 2006 Sep; 13(5):256-62. PubMed ID: 16998319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Congenital acute megakaryoblastic leukemia associated with trisomy 21].
    Gomis F; Pérez Sirvent ML; Borrego D; Sempere A
    Sangre (Barc); 1990 Dec; 35(6):485-6. PubMed ID: 2150895
    [No Abstract]   [Full Text] [Related]  

  • 9. [Manifestations of congenital leukemia as non-immunologic hydrops fetalis].
    González de Dios J; Moya Benavent M; Martínez García C; Juste Ruiz M; Carratalá Marco F; Mayol Belda MJ
    An Esp Pediatr; 1998 Apr; 48(4):417-20. PubMed ID: 9629804
    [No Abstract]   [Full Text] [Related]  

  • 10. Transient leukaemia in newborn infants with trisomy 21.
    Kwong YL
    Br J Haematol; 2003 Aug; 122(4):686-7. PubMed ID: 12899726
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydrops fetalis in a neonate with down syndrome, transient myeloproliferative disorder and hepatic fibrosis.
    Anuk D; Tarcan A; Alioglu B; Avci Z; Haberal N; Ozyurek E; Ozbek N
    Fetal Pediatr Pathol; 2007; 26(5-6):223-8. PubMed ID: 18363154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient leukemia followed by megakaryoblastic leukemia in a child with mosaic Down syndrome.
    Doyle JJ; Thorner P; Poon A; Tanswell K; Kamel-Reid S; Zipursky A
    Leuk Lymphoma; 1995 Apr; 17(3-4):345-50. PubMed ID: 8580807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrasomy 21 transient leukemia with a GATA1 mutation in a phenotypically normal trisomy 21 mosaic infant: case report and review of the literature.
    Sandoval C; Pine SR; Guo Q; Sastry S; Stewart J; Kronn D; Jayabose S
    Pediatr Blood Cancer; 2005 Jan; 44(1):85-91. PubMed ID: 15390279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demographic study of leukaemia presenting within the first 3 months of life in the Northern Health Region of England.
    Bajwa RP; Skinner R; Windebank KP; Reid MM
    J Clin Pathol; 2004 Feb; 57(2):186-8. PubMed ID: 14747447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the International System for Human Cytogenetic Nomenclature (ISCN).
    Gonzalez Garcia JR; Meza-Espinoza JP
    Blood; 2006 Dec; 108(12):3952-3; author reply 3953. PubMed ID: 17114573
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hydrops fetalis caused by congenital leukemia].
    Núñez E; Varela S; Cervilla K; Shalper J
    Rev Chil Pediatr; 1991; 62(3):186-8. PubMed ID: 1844930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient leukemia in newborns with Down syndrome.
    Massey GV
    Pediatr Blood Cancer; 2005 Jan; 44(1):29-32. PubMed ID: 15558701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder.
    Cushing T; Clericuzio CL; Wilson CS; Taub JW; Ge Y; Reichard KK; Winter SS
    J Pediatr; 2006 May; 148(5):687-9. PubMed ID: 16737888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonimmune hydrops fetalis due to generalized lymphatic dysplasia in an infant with Robertsonian trisomy 21.
    Ochiai M; Hikino S; Nakayama H; Ohga S; Taguchi T; Hara T
    Am J Perinatol; 2006 Jan; 23(1):63-6. PubMed ID: 16450276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Origins of leukaemia in children with Down syndrome.
    Hitzler JK; Zipursky A
    Nat Rev Cancer; 2005 Jan; 5(1):11-20. PubMed ID: 15630411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.